Transcriptome dynamics during human erythroid differentiation and development  by Yang, Yadong et al.
Genomics 102 (2013) 431–441
Contents lists available at ScienceDirect
Genomics
j ourna l homepage: www.e lsev ie r .com/ locate /ygenoTranscriptome dynamics during human erythroid differentiation
and development
a,2Yadong Yang a,1,2, Hai Wang a,1,2, Kai-Hsin Chang c,1,3, Hongzhu Qu a,2, Zhaojun Zhang a,2, Qian Xiong ,
Heyuan Qi a,2, Peng Cui b,2, Qiang Lin b,2, Xiuyan Ruan a,2, Yaran Yang a,2, Yajuan Li a,2, Chang Shu b,2,
Quanzhen Li d,4, Edward K. Wakeland a,d,4, Jiangwei Yan a,2, Songnian Hu b,⁎, Xiangdong Fang a,⁎
a Laboratory of Disease Genomics and Individualized Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China
b CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China
c Division of Hematology, Department of Medicine, University of Washington, Seattle, WA 98195, USA
d Department of Immunology & Microarray Core Facility, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA⁎ Corresponding authors at: No. 1-7 Beichen West Ro
China. Fax: +86 10 8409 7485.
E-mail addresses: yangyd@big.ac.cn (Y. Yang), wangha
kaihsin@u.washington.edu (K.-H. Chang), quhongzhu@big
zhangzhaojun@big.ac.cn (Z. Zhang), xiongq@big.ac.cn (Q.
cuipeng1022@gmail.com (P. Cui), linq@big.ac.cn (Q. Lin),
yangyr@big.ac.cn (Y. Yang), liyj@big.ac.cn (Y. Li), shuch@b
quan.li@utsouthwestern.edu (Q. Li), Edward.Wakeland@u
(E.K. Wakeland), yanjw@big.ac.cn (J. Yan), husn@big.ac.cn
(X. Fang).
1 These authors contributed equally to this work.
2 No. 1-7 Beichen West Road, Chaoyang, Beijing 100101
3 1705 NE Paciﬁc St., Box 357710, Seattle, WA 98195, U
4 5323 Harry Hines Blvd, Dallas, TX 75390, USA.
0888-7543/$ – see front matter © 2013 Elsevier Inc. All ri
http://dx.doi.org/10.1016/j.ygeno.2013.09.005a b s t r a c ta r t i c l e i n f oArticle history:
Received 24 June 2013
Accepted 30 September 2013






Gene regulatory networksTo explore the mechanisms controlling erythroid differentiation and development, we analyzed the genome-
wide transcription dynamics occurring during the differentiation of human embryonic stem cells (HESCs) into
the erythroid lineage and development of embryonic to adult erythropoiesis using high throughput sequencing
technology. HESCs and erythroid cells at three developmental stages: ESER (embryonic), FLER (fetal), and PBER
(adult) were analyzed. Our ﬁndings revealed that the number of expressed genes decreased during differentia-
tion, whereas the total expression intensity increased. At each of the three transitions (HESCs–ESERs, ESERs–
FLERs, and FLERs–PBERs), many differentially expressed genes were observed, which were involved in
maintaining pluripotency, early erythroid speciﬁcation, rapid cell growth, and cell–cell adhesion and interaction.
We also discovered dynamic networks and their central nodes in each transition. Our study provides a funda-
mental basis for further investigation of erythroid differentiation and development, and has implications in
using ESERs for transfusion product in clinical settings.
© 2013 Elsevier Inc. All rights reserved.1. Introduction
Two distinct waves of erythropoiesis occur during mammalian de-
velopment, namely primitive and deﬁnitive erythropoiesis. Primitive
erythropoiesis originates in the yolk sac and is characterized by the
transient circulation of large, nucleated erythroblasts. In contrast, deﬁn-
itive erythropoiesis is characterized by the continuous circulation of
small, enucleated erythrocytes, and in humans it can be further divided
into fetal erythropoiesis originated from the fetal liver (FL) and adult
erythropoiesis contributed by the bone marrow (BM) [1–3]. The mostad, Chaoyang, Beijing 100101,
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ghts reserved.distinctive characteristic of erythroid cells during each developmental
stage is the type of hemoglobin (Hb) expressed: embryonic erythroid
cells express Hb Gower 1 (ζ2ε2), Gower 2 (α2ε2), and Portland
(ζ2γ2); fetal erythroid cells express HbF (α2γ2); and adult erythroid
cells mainly express HbA (α2β2). Mechanisms underlying the changes
in Hb composition, known as Hb switching, during ontogenesis have
attracted extensive research [4], partly due to the fact that reactivating
developmentally silenced fetal γ globin can alleviate symptoms as-
sociated with hemoglobinopathies, e.g., sickle cell disease and β
thalassemia.
However, little is known about the similarities and differences be-
tween erythroid cells of each developmental stage beyond their Hb
compositions, morphologies, and to a degree, the extent of branching
in polylactosamine chain of their membrane glycoproteins [5]. The dif-
ﬁculties in obtaining embryonic globin-expressing erythroid cells par-
tially contribute to the lack of information concerning the properties
of these primitive cells. Recently large quantities of erythroid cells co-
expressing embryonic ε and fetal γ globins have been generated from
human embryonic stem cells (HESCs) and induced pluripotent stem
cells (HiPSCs) by several research groups [6]. Although these cells pos-
sess morphology more similar to deﬁnitive erythroid cells than those
of a primitive nature, the expression of high levels of embryonic ε globin
has caused some investigators to deﬁne these cells as primitive erythro-
blasts [6]. Although this discrepancy has not been resolved, these HESC-
and/or HiPSC-derived erythroid cells nevertheless represent erythroid
432 Y. Yang et al. / Genomics 102 (2013) 431–441cells from an earlier developmental stage than those of FL and BM and
may serve as a surrogate for early erythroid lineage cells that can pro-
vide insight into the changing properties of erythroid cells during
development.
In addition to shedding light on the developmental biology of ery-
throid cells, the investigation of HESC-derived erythroblasts (ESERs)
and/or HiPSC-derived erythroid cells may be clinically relevant. ESERs
and HiPSC-derived erythroblasts reportedly exhibit characteristics of
cord blood (CB) in terms of their oxygen dissociation curve, G6PD activ-
ities, CO rebinding kinetics, and response to 2,3-DPG depletion [7–9].
Cell enucleation can also occur under appropriate culture conditions [5].
Given that HESCs and HiPSCs can be maintained indeﬁnitely in vitro,
they may serve as donorless sources of red blood cells (RBCs) for trans-
fusion purposes. While the cost prohibits the replacement of conven-
tional blood concentrates with these in vitro-cultured erythroid cells,
they may be particularly useful clinically for polysensitized patients
with rare blood groups for whom cryopreserved blood is presently re-
quired. French researchers have proposed that as few as 15 HiPSC
lines would cover 100% requirements of all Caucasian patients with
rare blood phenotypes/genotypes in France [10]. A thorough investiga-
tion of the properties of these cells is therefore warranted.
In this study,we performed theﬁrst genome-wide expression proﬁl-
ing comparing the transcriptomes of four populations of cultured cells:
HESCs, ESERs, and FL-derived and adultmobilized peripheral blood (PB)
CD34+ cell-derived erythroblasts (FLERs and PBERs, respectively).
Using a series of bioinformatic approaches, we studied global gene
expression patterns, identiﬁed uniquely expressed genes in each popu-
lation, andmapped networks and central nodes involved in differential-
ly expressed genes. It is not surprising to ﬁnd that HESCswere distinctly
different from the three erythroid populations. However, we also ob-
served signiﬁcant differences among the three erythroid populations
beyond Hb-related transcripts. Our study provides rich resources for
further investigation on developmental regulation of erythropoiesis.
2. Results
2.1. RNA-Seq of HESCs and erythroid cells of different developmental stages
The surface markers and differential globin expression by respective
erythroid cells used in this study have been reported previously [11]. To
characterize the transcriptomes of HESCs and three developmentally-
distinct erythroid populations (ESERs, FLERs, and PBERs), four libraries
were generated andused for RNA-Sequsing theABI SOLiD Sequencing Sys-
tem. Approximately 45–124million reads (50bp in length) were obtained
andmapped to the humangenome. Among these reads, 8–37million reads
weremapped to a unique locus, whereas 2–10million readsweremapped
tomultiple loci (Table S1). Despite the different sequencing depths obtain-

























Fig. 1. Quality analysis of RNA-Seq data. (A) Fraction of genes detected as a function of read de
genes detected in genes from theNational Center for Biotechnology Information (NCBI) databas
and PBERs. The selected genes are FOXO1, SOX4, TET1, BLVRA, CAT, TXNIP, HBE, HBG1, HBB, GATapproached saturation for all four cell types (Fig. 1A), as similarly described
in another transcriptome study [12]. Most of these reads were mapped to
exons, introns, and intergenic regions, whereas a small fraction (4.3%,
4.3%, 2.8%, and 2.7% for HESCs, ESERs, FLERs, and PBERs, respectively) of
them were mapped to exon–intron junctions. More reads were mapped
to exons than to introns in HESCs, ESERs, and FLERs. In contrast, more
reads were mapped to introns than exons in PBERs, which is consistent
with another PB transcriptome dataset in our group (unpublished data),
and the reasons for this remain unknown. The coverage for each run was
normalized to RPKM values to facilitate quantitative comparisons between
genes and runs [13].
To validate the sequencing data, we quantitated the expression of
erythroid-related genes in these four cell populations using qRT-PCR.
On the basis of transcript levels for FOXO1, SOX4, TET1, BLVRA, CAT,
TXNIP, HBE, HBG1, HBB, GATA1, and KLF1, the logarithmic transforma-
tions of RPKM values and relative copy numbers of qRT-PCR were com-
pared [14]. Results of the present study revealed that RNA-Seq data
correlated well with qRT-PCR data (pb0.0001; R2=0.734; Fig. 1B).
2.2. Distinct gene expression patterns during differentiation and development
We used hierarchical cluster analysis to sort the expressed genes in
these four cell types. Genes as well as samples with similar expression
patterns were clustered together. The branch length between genes
(Fig. 2A, left side) or samples (Fig. 2A, top) is proportional to their similar-
ity in expression pattern (Fig. 2A). Among the four cell types, FLERs and
PBERs were clustered together, indicating that they shared similar ex-
pression patterns. Furthermore, FLERs and PBERs clustered with ESERs
before they clustered with HESCs.
In addition, genes with similar expression patterns were also
clustered together. As shown in Fig. 2A, we found that the majority of
clustered genesweremainly down-regulated during erythroid differenti-
ation and development. In contrast, fewer genes were developmentally
up-regulated. Furthermore, some genes were up- or down-regulated at
a speciﬁc stage (Fig. 2A).
We also compared the number of expressed genes and the expres-
sion intensity across the four cell types (Figs. 2B–C). In total, 23244 tran-
scriptswere expressed in at least one of the four cell types. Among these
transcripts, three non-mutually exclusive groups were identiﬁed in
each cell type: “expressed,” “not expressed,” and “uniquely expressed”
(transcripts expressed by only one speciﬁc cell type). In total, 22072
“expressed” genes were detected in HESCs, which was the highest
among the four cell types, followed by ESERs (18847), PBERs (15900),
and FLERs (15863). Similarly, the number of “uniquely expressed” tran-
scripts was the highest in HESCs (3614), comparedwith 401, 65, and 59
transcripts for ESERs, FLERs, and PBERs, respectively. GO enrichment
analysis showed that multicellular organismal process, signaling and
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Fig. 2. Gene expression dynamics during differentiation. (A) Hierarchical clustering of genes expressed in HESC, ESER, FLER, and PBER cells. Each row represents a gene, and each column
represents a cell type at different stages. Expression intensities are displayed from green (low expression) to red (high expression). Lines on the top and left represent the similarity be-
tween cell types and genes, respectively. Genes and cell types with the most similar expression proﬁles were clustered together with the shortest branches and represented in the
dendrogram to illustrate their relationship. (B) Number of genes expressed in four cell types. All: genes expressed in at least one of the four cell types; not expressed: absent relative
to “All”; uniquely expressed: expressed only in one cell type. (C) The total expression intensity of genes in four cell types. X-axis: four kinds of cell types; Y-axis: the expression intensity
of all genes.
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stem cells. The unique genes in ESERs were enriched in immune re-
sponse and membrane-related functions. There were not signiﬁcantly
enriched categories in unique genes in FLERs and PBERs (Table S2). In
contrast to “expressed” and “uniquely expressed” transcripts, the num-
ber of “not expressed” transcripts increased dramatically with the
developmental stages (944, 4182, 7198, and 7162 for HESCs, ESERs,
FLERs, and PBERs, respectively; Fig. 2B).
However, despite the highest number of expressed genes in HESCs,
HESCs had the lowest total expression intensity among these four cell
types. The highest expression intensity was detected in ESERs, which
was 2.4-fold of that in HESCs (the sum of RPKM was 736388 and
1765840 in HESCs and ESERs, respectively). From ESERs to FLERs, the
total expression intensity decreased by 42.1%, while a similar intensity
was found between FLERs and PBERs (the sum of RPKM values was
921604 and 1025020 in FLERs and PBERs, respectively; Fig. 2C).
2.3. Differential expression of unique classes of genes during erythroid
differentiation and development
Gene expression patterns were compared for the following three
pairs: HESCs vs. ESERs, ESERs vs. FLERs, and FLERs vs. PBERs. Expression
intensities were calculated by logarithmic transformation of RPKM
values and compared. Using a 2-fold and p≤0.01 cutoff for differential
expression, genes were deﬁned as up-regulated (U), down-regulated
(D), or unchanged (ﬂat, F) in each comparison. In total, 27 gene assem-
blieswere thus identiﬁed on the basis of differential expression status of
each gene (up-regulated, down-regulated, or ﬂat) in each of the three
comparisons (Fig. 3). These 27 assemblies were further combined into
nine categories as follows: UXX, DXX, FXX, XUX, XDX, XFX, XXU, XXD,
and XXF, with X representing Up-regulated, Down-regulated, or Flat.
Then, the gene function in each category was evaluated using GO anal-
ysis (Table 1).
We found that genes in the UXX category were signiﬁcantly
enriched in immune system development, hematopoietic or lymphoidorgan development, erythrocyte homeostasis, and erythrocyte differen-
tiation, such as HBZ, GATA1, TAL1 and KLF1, coinciding with the com-
mitment of HESCs to hematopoietic/erythroid lineage. Genes involved
in cell adhesion, cell projection, anatomical structure, and the nervous sys-
temwere signiﬁcantly enriched among down-regulated genes in HESC vs.
ESER comparison (DXX), which is consistent with the fact that ESERs are
unipotent, differentiated, non-adherent cells and HESCs are pluripotent
stem cells. Pluripotency genes, such as POU5F1, NANOG, and SOX2 were
down-regulated in ESER compared with HESC. Genes related to primary
metabolic processes, macromolecule metabolic processes, cellular meta-
bolic processes, RNA processing and translation, and gene expression
were not signiﬁcantly altered in ESERs compared with HESCs (FXX), sug-
gesting that the primary metabolic function was not affected by lineage
commitment. The ESER–FLER comparison revealed that in the XUX cate-
gory, genes involved in intracellular activities, cell cycle, and cell division,
such as spindle and kinetochore associated complex subunit 1 (SKA1),
SKA3, cyclin B1 (CCNB1), CCNA2, anaphase-promoting complex subunit 11
(ANAPC11), cell division cycle associated 2 (CDCA2), and CDCA3 were
enriched. In contrast, genes involved in the regulation of cell communica-
tion and cytoskeletal protein binding and those extrinsic to membrane
were enriched in XDX. Interestingly, these genes included RAS p21 protein
activator 3 (RASA3) and RASA-like 1 (RASAL1), both of which suppress the
RAS signaling pathway, potentially inhibiting cell proliferation. In addition,
geneswithin this category included several regulators for G protein signaling
(RGS), including RGS5, RGS6, RGS10 aswell as RGS14, all ofwhich inactivate
the G protein-coupled receptor signaling pathway. Down-regulation of
negative regulators of the RAS signaling pathway and G protein signaling
pathway suggests that FLERs have heightened sensitivity to extracellular
signals and increased proliferation potential compared with ESERs. Genes
involved in cell adhesion and biological adhesion were enriched in the
XFX category, indicating that the adhesion properties may not be the
major determinant that distinguishes ESERs from FLERs. Comparison be-
tween fetal and adult erythroid cells revealed that genes involved inmem-
branes and organelles were enriched in XXU and XXD, respectively,
indicating structural differences between these two populations (Tables 2
Fig. 3.Quantiﬁcation of dynamic transcriptome changes during erythroid differentiation. According to gene expression intensity, 27 patterns were identiﬁed. Capital letters represent the
three transcriptome changes during erythroid differentiation and development, e.g., theﬁrst letter represents changes fromHESCs to ESERs, the second one represents changes fromESERs
to FLERs, and the third one represents changes from FLERs to PBERs. (U, up-regulated; D, down-regulated; and F, ﬂat or unchanged). Each line represents the gene expression dynamics.
We thank Wu JQ et al. [12] for the model.
434 Y. Yang et al. / Genomics 102 (2013) 431–441and S3). Interestingly, aquaporin 1 (AQP1) was found in the XXU category.
Consistent with our ﬁnding, increased expression of AQP1 has been found
when comparing adult erythrocytes with fetal erythrocytes [15]. Further-
more, BCL11A and SOX6 were found to be up-regulated in PBER cells in
which adult beta globin (HBB) was highly expressed whereas embryonic
epsilon (HBE1) and fetal gamma (HBG1 and HBG2) globin genes were
down-regulated, in agreement with the important roles of BCL11A and
SOX6 in mediating hemoglobin switching during ontogenesis [16–18].
The expression levels of genes mentioned above were summarized in
Table S3. In addition, of the four cell populations studied here, the FLER
vs. PBER comparison has been performed at the proerythroblast stage
(day 5) by Xu and colleagues [19]. Despite the differences in culture
media employed and in the length of culture (day 14 in our present
study), a large number of shared up-regulated and down-regulated tran-
scriptswere identiﬁedwhen comparing our RNA-Seq dataset to themicro-
array dataset by Xu et al. (Fig. S1 and Table S4). The genes discussed above
such as AQP1 and BCL11A were among the differentially expressed genes
identiﬁed in both datasets.
2.4. Identiﬁcation of gene regulatory networks and central nodes involved
in erythroid differentiation and development
Up-regulated genes inHESC–ESER, ESER–FLER, and FLER–PBER com-
parisons were organized into interactome networks using IPA. The top
ﬁve functional networks of each of the three comparisons (Table 2)
were selected and combined into a bigger network based on the IPA
Knowledge Base (Fig. 4). For each network, node-edge statistics were
performed to identify central nodes (Table S5). In the HESC–ESER
comparison, we found 17 central nodes (Fig. 4A). RELA (also known asNFKB3) is an important factor in NFκB signaling, which is involved in
the control of a variety of cellular processes, including cell survival, pro-
liferation and immune responses [20]. RUNX1 lies downstreamof Notch
signaling in zebraﬁsh,which is essential for the induction of hematopoi-
esis [21]. RUNX1 knockout results in a complete absence of murine
deﬁnitive hematopoiesis [22] and causes abnormal morphology in
primitive erythrocytes [23]. MAPK14 (P38MAPK) controls erythroblast
enucleation [24]. Foxo3 is required for the regulation of oxidative stress
in erythropoiesis in mice [25] and Foxo3 knockdown in K562 and TF-1
cells led to a striking reduction in globin expression (unpublished
data). VEGF, which promotes erythropoiesis of HESCs [26] was also
identiﬁed as a central node. Furthermore, multiple genes identiﬁed as
central nodes, such as RUNX1, RELA, and STAT are involved in the
fms-like tyrosine kinase-3 (FLT3) signaling pathway, which plays an
important role in the survival, proliferation and self-renewal of early he-
matopoietic progenitors [27,28] (Fig. 5A). In the ESER–FLER compari-
son, we identiﬁed 5 central nodes (Fig. 4B) and many of these genes
are regulators of cell proliferation. PCNA (the Proliferating Cell Nuclear
Antigen) and BIRC5 (also known as Survivin), both involved in facilitat-
ing cell proliferation,were up-regulated. In contrast, negative regulators
of cell cycle progression, including CDKN1A (P21, Cip1) and CDKN2A
(Fig. 5B), were down-regulated. These data are consistent with our GO
analysis that FLERs were actively cycling as compared to ESERs. In the
FLER–PBER comparison, we identiﬁed 9 central nodes (Fig. 4C). Several
of these central nodes, such as CD44, ITGB1, MAPK1 (ERK2) and MAPK3
(ERK1), are molecules involved in cell–cell interaction/adhesion/
migration or its downstream pathways (Fig. 5C). CD44 has been used
to separate murine [29] and human [30] erythroid precursors of differ-
ent maturation stages. Integrin beta 1 (ITGB1) has been shown to be
Table 1
GO enrichment of nine gene categories during the differentiation process.
GO description p-Value
UXX Erythrocyte differentiation 1.38E−12
Response to stress 2.87E−10
Immune system development 1.75E−08
Oxygen transporter activity 8.00E−04
Regulation of erythrocyte differentiation 9.15E−08
Erythrocyte homeostasis 2.36E−12
Myeloid cell differentiation 3.70E−12
Hematopoietic or lymphoid organ development 2.93E−09
DXX Nervous system development 4.47E−39
Cell adhesion 6.65E−31
Anatomical structure morphogenesis 7.01E−35
Cell projection 5.01E−36
Synapse 2.03E−26
FXX Gene expression 3.84E−07
Translation 5.22E−06
Primary metabolic process 4.06E−06
Cellular metabolic process 4.09E−07
Macromolecule metabolic process 5.22E−06
XUX Nuclear division 1.21E−15
Intracellular 1.68E−24
Organelle 3.30E−13
Structure-speciﬁc DNA binding 2.00E−04
Cell cycle 1.26E−23
Purine nucleotide binding 7.00E−04
XDX Regulation of cellular process 6.35E−13
Regulation of nitrogen compound metabolic process 7.18E−12
Kinase binding 1.32E−06
Cytoskeletal protein binding 1.01E−07
XFX Cell adhesion 6.33E−08
Biological adhesion 6.33E−08
XXU Receptor binding 2.15E−02
Membrane 3.90E−03
Regulation of cellular metabolic process 8.16E−05
Membrane raft 4.30E−03
XXD ncRNA metabolic process 3.46E−38
Organelle 1.84E−81
Ribonucleoprotein complex biogenesis 7.71E−35
mRNA metabolic process 5.38E−47
XXF Cell adhesion 4.79E−17
Intracellular 2.03E−22
U, up-regulated; D, down-regulated; F, ﬂat (b2-fold change); X, Up-regulated, Down-
regulated, or Flat. UXX was assembled from UUU, UUD, UUF, UDU, UDD, UDF, UFU, UFD
and UFF The other eight categories in Table 2 were assembled similarly.
435Y. Yang et al. / Genomics 102 (2013) 431–441indispensable for adult mice to recover from hemolytic stress [31] and
may also be important for the proliferation and survival of murine FL
erythroid progenitors [32]. The implication of differential expression
of these adhesion molecules in FLERs vs. PBERs is not clear but may be
reﬂective of the different properties of erythroid niches in fetal vs.
adult stages. The expression levels of these central nodes were summa-
rized in Table S6. Deletion of any of these nodes would disturb or
destroy the network. The differential expression of some of these iden-
tiﬁed central nodeswas further validated using qRT-PCR and the results
were in line with the RNA-Seq data (Fig. 6).
3. Discussion
Recently, studies have been conducted to analyze the dynamic
changes in the transcriptome of mouse primitive erythroid progenitors
from the yolk sac [33] and human adult erythroid progenitors frommo-
bilized PB [34,35] over the course of their differentiation and terminal
maturation. A host of genes with unknown functions in the terminal
maturation of erythroblasts have been identiﬁed which may facilitate
future functional studies of terminal erythropoiesis. In this study, a
different approach was taken and comprehensive analysis was per-
formed to compare the transcriptome of erythroblasts of different de-
velopmental stages rather than of different maturity. In addition, the
transcriptome of HESCs and their erythroid progeny (ESERs) was also
compared.With the ability to self-renew indeﬁnitely and also differentiate into
cells of three germ layers, HESCs has been studied extensively to map
the regulatory network contributing to their stemness [36,37]. Consis-
tent with previous ﬁndings when comparing undifferentiated HESCs
and differentiated cells [38,39], we found that HESCs expressed more
genes globally than differentiated ESERs, although at lower overall
expression intensity. The global transcription hyperactivity has been
proposed to contribute to the plasticity of ESCs [40]. Upon differentia-
tion, a large portion of these genes was turned off which included tran-
scription factors critical to pluripotency, such as POU5F1, SOX2, and
NANOG (Table S3). This large number of genes was replaced by fewer,
yet highly expressed, erythroid/hematopoietic lineage-speciﬁc genes,
such as GATA1, KLF1, and TAL1. Network analysis between these two
cell types also identiﬁed factors known to be important for erythropoi-
esis, such as RUNX1 and MAPK14 [21,24], as well as VEGF, which
promotes erythropoiesis in HESCs [26], to be the central nodes.
Since HESCs are fundamentally different from erythroid cells, it is not
surprising that HESCs had a unique gene expression pattern when com-
pared to the three erythroid populations (Fig. 2A). However, examination
of the transcriptome of these three erythroid populations also revealed a
large number of genes thatwere differentially expressed. These differences
may have stemmed from the developmental stages that these erythroid
cells were situated in. As PBERs clustered with FLERs before they clustered
with ESERs (Fig. 2A), it indicates that ESERs were less similar to these two
deﬁnitive stage erythroid populations, than PBERs and FLERs were to each
other, despite thedeﬁnitivemorphologyof ESERs [41]. This is in accordance
with the ﬁnding that progeny of HESCs and HiPSCs, including neural, he-
patic, and mesenchymal lineages, are developmentally immature and re-
ﬂective of early human development (b6 week gestation), compared
with their adult-derived counterparts [42]. Furthermore, a list of genes in-
cluding IL8, several MHC class molecules, and Hb molecules have been
found to be differentially expressed by HESC-derived CD34+ CD38− cells
and by CD34+CD38− cells originating from adult tissue [43]. Coincidental-
ly, the same patterns were foundwhen comparing the expression of these
genes in ESERs to that in PBERs (Table S3). These data suggest that the
progenymay retain certain gene expression signature of their correspond-
ing precursors and/or certain developmental stage speciﬁc genes may al-
ready be primed in the multipotent progenitor/precursor stage. Finally, as
several molecules involved in cell–cell interaction/adhesion/migration or
its downstreampathway constituted the central nodes in FLER–PBER com-
parison, it underscores the potential differences in the erythroid niches at
the fetal and adult stages that require further investigations.
In addition, the differences observed between the three erythroid
cell groups may be due to the different degrees of maturation attained
by the three erythroid populations [35]. Several cell proliferation-
related genes (including CCNB1, CCNA2, and CDCA3), and membrane
and organelle-related genes (such as NOP16 and GOLM1) that are
known to be down-regulated during erythroid maturation [34] had
notably higher expression intensity in FLERs than in ERERS or PBERs.
This unique expression proﬁle may suggest that FLERs used in this
study were potentially less terminally differentiated than were ESERs
or PBERs, if the gene expression patterns shift similarly during erythroid
differentiation/maturation regardless of their developmental stages. Co-
incidentally, CD71 and CD36, two markers whose expression decreases
during erythroidmaturation [44],were found to bemost highly expressed
by FLERs as compared to ESERs and PBERs (Fig. S2). On the other hand,
many genes, such as ITGB1, GGA1, TMC8, AQP1, CTNNB1, and RGS6
whose expressions remain constant during erythroid differentiation
[34], yet were identiﬁed to be differentially expressed in the three ery-
throid populations in our study, may truly reﬂect developmentally-
regulated genes. To better address this issue, sub-fractionating of ery-
throid cells from these three developmentally distinct stages into
separate differentiation stages may be required.
Our study has conﬁrmed the expression status of various well-
validated critical factors forHESCspluripotency aswell as for erythroiddif-
ferentiation and development. In addition, our comprehensive analyses
Table 2
Top ﬁve functions enriched in UXX, XUX, and XXU.
ID Score Focus molecules Top function
UXX
1 29 35 Cellular growth and proliferation, hematological system development and function, organismal injury
and abnormalities
2 24 33 Endocrine system disorder, metabolic disease, dermatological diseases and conditions
3 19 30 Cellular development, hematological system development and function, hematopoiesis
4 12 16 Cell morphology, cellular compromise, genetic disorder
5 10 22 Inﬂammatory response, cellular movement, hematological system development and function
XUX
1 18 16 RNA post-transcriptional modiﬁcation, antigen presentation, cell-to-cell signaling and interaction
2 14 14 DNA replication, recombination, and repair, molecular transport, nucleic acid metabolism
3 12 18 Cellular development, cell-mediated immune response, cellular function and maintenance
4 10 16 Cell cycle, connective tissue development and function, gene expression
5 9 15 Cellular development, cellular growth and proliferation, cell cycle
XXU
1 26 30 Cell-to-cell signaling and interaction, tissue development, cellular growth and proliferation
2 17 24 Cancer, cellular development, hair and skin development and function
3 14 22 Cellular growth and proliferation, DNA replication, recombination, and repair, cardiovascular disease
4 13 21 Cellular growth and proliferation, cellular development, connective tissue development and function
5 13 15 Cellular assembly and organization, infection mechanism, cellular compromise
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among these populations that are previously unknown. Although investi-
gating erythropoiesis/hematopoiesis using HESCs and HiPSCs will
continue to provide invaluable insights into early events of human onto-
genesis, it is crucial to keep in mind, when employing them for disease
modeling, that ESERs and other HESC-/HiPSC-derived progeny are devel-
opmentally immature and may not properly represent their adult
counterparts.Moreover, given that the transcriptomeof ESERs is substan-
tially different from that of PBERs, the perturbance in transcription
network may result in the presentation of unusual blood group pheno-
types, as has previously been documented with KLF1 mutations [45].
This may have implication in the potential clinical usefulness of erythroid
cells derived fromHESCs orHiPSCs as blood concentrates. However, it is re-
cently reported that erythroid cells derived from HiPSCs can reach com-
plete terminal maturation in vivo, including the fetal to adult globin
switch [46], whether the transcriptome of these HESC-/HiPSC-derived ery-
throid precursors, once exposed to the in vivo environment,wouldbecome
more similar to their adult counterparts remain to be evaluated.
4. Materials and methods
4.1. Cell cultures and erythroid differentiation
ESERs were generated from human HESC line H1 (NIH code WA01,
WiCell, Madison, WI) as described previously, with slight modiﬁcations
[47]. In brief, conﬂuent HESCs cultured on murine embryonic ﬁbroblast
feeder layers were harvested by dispase (Invitrogen, Carlsbad, CA)
treatment. HESC clumps were transferred into an embryoid body
formation medium composed of Iscove MEM (IMDM; Hyclone, Logan,
UT), 15% ES-qualiﬁed FBS (Invitrogen), 10% protein-free hybridoma
medium II (PFHM-II; Invitrogen), 300 μg/mL iron-saturated human
transferrin (Sigma-Aldrich, St. Louis, MO), 50 μg/mL ascorbic acid (Sigma-
Aldrich), 0.1 mM β-mercaptoethanol, 1× penicillin/streptomycin, and
2mM L-glutamine (Mediatech, Herndon, VA). After 7days, single cell sus-
pensions were obtained by digesting embryoid bodies with a 1:1 mixture
of dispase (1.2U/mL) and collagenase IA (10%) (Sigma-Aldrich), embryoid
bodies were forced through a 21G needle, and then were subjected to a
second digestion with Accutase (Innovative Cell Technology, San Diego,
CA). Next, cell suspensions were placed in an erythroid inductionmedium
composed of Stemline hematopoietic stem cell growth and expansion
medium (Sigma-Aldrich) supplemented with 2mM L-glutamine, 1×
penicillin/streptomycin, 0.1 mM MEM nonessential amino acids (allfrom Mediatech), 0.1 mM β-mercaptoethanol, 200 μg/mL iron-
saturated transferrin,10 μM ethanolamine, 10 μg/mL insulin (all from
Sigma-Aldrich), 6U/mL erythropoietin, 50ng/mL stem cell factor (both
from Amgen, Thousand Oakes, CA), 20 ng/mL interleukin-3, 20 ng/mL
interleukin-6, 40ng/mL insulin-like growth factor-1, 10ng/mL vascular
endothelial growth factor (all from Peprotech, Rocky Hill, NJ), 5%
protein-free hybridoma medium, 1× insulin–transferrin–selenium
(both from Invitrogen), and 1× EX-CYTE (Millipore, Billerica, MA).
Fourteen days after culture, staining with anti-glycophorin-A anti-
body (DAKO, Glostrup, Denmark) revealed that N95% of cells were
erythroid cells [11]. These cells were harvested for analyses.
CD34+ cells from healthy volunteer-donor mobilized PB (MPB
CD34+ cells) were obtained from the NIH repository (Fred Hutchinson
Cancer Research Center) and FL cells (50–100-day gestation) were ob-
tained from the fetal tissue repository (University of Washington Birth
Defects Research Laboratory), both with permission of the University
of Washington Institutional Review Board. MPB CD34+ cells and disso-
ciated FL cells were cultured in the same erythroid-inducingmedium as
described above to generate adult- and fetal-type erythroid cells. At the
end of the culture, cell composition was determined by ﬂow cytometry
[11]. ESERs and PBERs were N90% positive for glycophorin-A [11] and
were used as is for subsequent gene expression analysis. Because only
~50% of cells of FL culture expressed glycophorin-A, FLERs were enriched
to over 95% purity using MACS system as per the manufacturer's instruc-
tion (Miltenyi Biotec, Auburn, CA). The surface expression of CD71 or
CD36 by glycophorin-A+ erythroblasts was also analyzed by ﬂow
cytometry using Fluorescein isothiocyanate-conjugated anti-CD71 or
Allophycocyanin-conjugated anti-CD36 antibodies (both from BD Biosci-
ences, San Jose, CA). Cells were acquired using FACScalibur (BD Biosci-
ences), and the results were analyzed with Flowjo X (Tree Star Inc.,
Ashland, OR). Gatings were set according to isotype controls.
4.2. RNA extraction and cDNA library preparation
Total RNA was extracted from HESC, ESER, FLER, and PBER cells
using TRIzol® Reagent (Invitrogen) as per the manufacturer's in-
structions. HESC, ESER, and FLER cells were each derived from one
batch of culture whereas two batches of PBER cultures were obtain-
ed. Using the Ribosomal RNA Depletion Kit (ABI, Carlsbad, CA), 18S
rRNA and 28S rRNA were rapidly depleted from total RNA before
cDNA library was constructed using the SOLiD™ Whole Tran-
scriptome Analysis Kit (ABI).
Fig. 4.Genenetworks and central nodes involved in erythroid differentiation and development. Genes involved in the three stage transitionswere analyzed using Ingenuity PathwayAnal-
ysis (IPA). Orange gene symbols indicate genes that appeared inUXX, XUX, or XXU.White gene symbols indicate genes not identiﬁed inUXX, XUX, or XXU. Geneswith a score N2-fold the
average score of the network are deﬁned as central nodes. (A) A gene network of 17 central nodes constructed using genes up-regulated in ESERs compared with HESCs (UXX). (B) Net-
work analysis of up-regulated genes in FLERs vs. ESERs, with 5 central nodes (XUX). (C) A gene network constructed using genes up-regulated in PBERs vs. FLERs, with 9 central nodes
(XXU).
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Transcriptome sequencing was conducted using the Applied Bio-
systems SOLiD System according to the manufacturer's protocol, and
the read length was 50bp. The sequencing read data can be accessed in
the Gene Expression Omnibus (GEO) database under the accession ID
GSE32991.4.4. Quantitative real-time PCR (qRT-PCR)
Total RNA was extracted as described above and reverse tran-
scribed using the RevertAid™ First Strand cDNA Synthesis Kit
(Fermentas, Glen Burnie, MD). qRT-PCR was performed on the
CFX96 Real-Time PCR Detection System (Bio-Rad, Hercules, CA)
using Maxima® SYBR Green/ROX qPCR Master Mix (Fermentas).
Fig. 5. Pathways activated in each comparison. Pathways activated in the three stage transitions containing central nodes were identiﬁed using IPA. (A) Activation of the FLT3 signaling
pathway in ESER cells comparedwith that inHESCs. (B) Activation of cyclins and cell cycle regulation pathway in FLER cells comparedwith that in ESER cells. (C) Activation of ILK signaling
pathway in PBER cells comparedwith that in FLER cells. Red and green represent up-regulated and down-regulated genes, respectively. The extent of regulation is based on the color grade.
Symbols with gradient colors indicate a gene family whose members change in different degree.
438 Y. Yang et al. / Genomics 102 (2013) 431–441Primers were designed using Primer 5 and PrimerBank (http://pga.
mgh.harvard.edu/primerbank/index.html). Transcript levels were
normalized to that of glyceraldehyde 3-phosphate dehydrogenase.
The samples used for qRT-PCR were the same ones used for RNA-
Seq in all groups except for PBER cells, which were obtained from a
separate batch of culture.4.5. Gene expression analysis
Corona_lite_plus (version 4.2.1) software (ABI)was used tomap our
sequence reads to the human reference sequence (hg18). Reads of rRNA
were ﬁltered at the beginning of read mapping, with a full length of
50bp. Subsequently, the remaining readsweremapped to the reference
Fig. 6. The relative expression levels of selected central nodes in four cell populations as determined by qRT-PCR.
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eachmapping step. Readsmapped to unique loci and a fraction of those
mapped to multiple loci (2–10) were used for further analysis.
To calculate gene expression intensity, the read countswere normal-
ized to reads per kilobase of exon model per million mapped reads
(RPKM) according to the gene length and total mapped reads [13]. To
avoid background noise disturbance accompanying sequencing experi-
ments and to ensure a reliable output, spots where RPKM was b0.01
(approximately ﬁve corresponding reads on average when the signal
could not be detected using qRT-PCR) for genes in all four libraries
were removed from analyses.4.6. Differentially expressed gene analysis
For the RNA-Seq data, we used DEGseq [48] to identify differentially
expressed genes (DEG) between samples based on the following
criteria: p≤0.01 and fold change≥2. For themicroarray data from pub-
lic resource, we used geo2R on NCBI to identify DEG based on the
criteria: FDR≤0.05.4.7. Cluster analysis
Logarithmic transformation to gene expression intensity was exe-
cuted before clustering. Average linkage hierarchical clusteringwas per-
formed in this study using Pearson distance as the distance measurebetween genes and samples. Computation and visualization were
achieved using heatmap plus package in R.
4.8. Gene Ontology (GO) analysis
WebGestalt, a “Web-basedGene SeTAnaLysis Toolkit,”was used forGO
analysis with the following parameters: “hypergenometric distribution” as
statistical method, “BH” as multiple test adjustment, “top 10” as the signif-
icance level, and “2” as the minimum number of genes for a category.
4.9. Gene network analysis
Network analyseswere performed using Ingenuity Pathways Analy-
sis (IPA, Ingenuity® Systems, www.ingenuity.com). Ingenuity Knowl-
edge Base is the largest manually curated database based on previous
scientiﬁc literature [49]. From a list of genes with particular expression
features, IPA produces networks according to its algorithm. The signiﬁ-
cance of the network is calculated using Fisher's exact test. In the net-
work, the score of one node is obtained using the following equation:





























where kin is the number of genes regulating the gene examined, kout is
the number of genes regulated by the gene examined, and knd is the
number of genes without afﬁrmatory regulatory directions.k− in, k
−
out,
440 Y. Yang et al. / Genomics 102 (2013) 431–441and k−nd represent the average values of kin, kout, and knd, respectively.
Genes with a ratio of score= score− N2 and fold changeN2 are deﬁned as
central nodes.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ygeno.2013.09.005.
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